Effective Interventions to Overcome Severe Gag Reflex
1 other identifier
interventional
45
1 country
1
Brief Summary
The purpose of this study is to evaluate the use of various techniques in alleviating gag reflex following gag reflex stimulation. Primary aim: To compare if there is any reduction in gag reflex from each of the following interventions
- Acupuncture (CV-24)
- Tape
- Anesthetic spray Secondary aim: to compare the degree of gag reduction
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1
Started Dec 2025
Typical duration for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2025
CompletedFirst Posted
Study publicly available on registry
August 1, 2025
CompletedStudy Start
First participant enrolled
December 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 7, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 7, 2028
August 1, 2025
July 1, 2025
2 years
July 8, 2025
July 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Gag Reflex Severity Index (GSI) Score From Pre- to Post-Intervention
Change in Gag Reflex Severity Index (GSI) Score From Baseline to Post-Intervention * Acupuncture (CV-24) * Tape * Anesthetic spray Gag reflex severity will be assessed by clinicians using the Gagging Severity Index (GSI), based on definitions set by Dickinson and Fiske. GSI will first be recorded after initial gag stimulation with a cotton swab. Following randomization to one of three interventions (acupuncture, anesthetic spray, or masking tape), GSI will be recorded again. The change in GSI score will be used to measure change in gag response.
90 minutes per subject
Secondary Outcomes (1)
Self-Reported Degree of Gag Reflex Reduction Using Visual Analog Scale (VAS)
Immediately post-intervention during single study visit
Study Arms (3)
Acupuncture (CV-24)
EXPERIMENTALA 6C file (endodontic instrumentation file) will be placed on the patient's mentolabial fold (CV24). This file will be concealed by a small paper cup; A clean alcohol wipe will be used to clean the mentolabial area prior to placing the "acupuncture needle" (6 C-File).
Tape
EXPERIMENTALA piece of commercially available masking tape will be adhered to the patient's mentolabial fold and concealed by the small paper cup
Anesthetic spray
EXPERIMENTALWill be applied to back of the throat for 10 seconds; their chin will also be concealed from the GSI examiner using a small cup and masking tape.
Interventions
will be applied to back of the throat for 10 seconds; their chin will also be concealed from the GSI examiner using a small cup and masking tape.
A 6C file (endodontic instrumentation file) will be placed on the patient's mentolabial fold (CV24). This file will be concealed by a small paper cup; A clean alcohol wipe will be used to clean the mentolabial area prior to placing the "acupuncture needle" (6 C-File).
A piece of commercially available masking tape will be adhered to the patient's mentolabial fold and concealed by the small paper cup
Eligibility Criteria
You may qualify if:
- years or older (individuals below 18 years will be excluded from the study as the study procedures might not be well tolerated by them, and they are not the primary population on which these procedures are used).
- Students, faculty, or staff of Tufts SDM
- Subjects who score a 2 or higher on the Gagging Severity Index (GSI)7 and have a positive gag reflex response when stimulated with a cotton swab at the base of the tongue/uvula/tonsil region.
You may not qualify if:
- Adults unable to consent (cognitively impaired adults)
- Wards of the state
- Pregnant women (those that are self-reported)
- Current use of anticoagulants
- Allergy to xylocaine
- Those with bleeding disorders
- Those who participated in the Calibration phase of this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tufts Universitylead
Study Sites (1)
Tufts University School of Dental Medicine
Boston, Massachusetts, 02111, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Devon Ptak
Tufts University School of Dental Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2025
First Posted
August 1, 2025
Study Start
December 7, 2025
Primary Completion (Estimated)
December 7, 2027
Study Completion (Estimated)
December 7, 2028
Last Updated
August 1, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share